The etiology of multiple sclerosis (MS) is considered to involve genetic, environmental, infective, and immunological factors which affect the integrity of a normally assembled myelin sheath, either directly or indirectly resulting in demyelination. In a correlative study involving protein chemical, mass spectrometric, and electron microscopic techniques we have determined that myelin obtained from victims of MS is arrested at the level of the first growth spurt (within the first 6 yr of life) and is therefore developmentally immature. The data supporting this conclusion include (a) the pattern of microheterogeneity of myelin basic protein (MBP); (b) the NH2-terminal acylation of the least cationic component of MBP ("C-8"); (c) the phase transition temperature (Tc) of myelin isolated from victims of MS correlated with the increased proportion of the least cationic component of MBP; and (d) immunogold electron microscopy using an antibody specific for "C-8" showed that the distribution of gold particles in a 2-yr-old infant was similar to the distribution found in a victim of MS. We postulate that this developmentally immature myelin is more susceptible to degradation by one or a combination of factors mentioned above, providing the initial antigenic material to the immune system.
M A Moscarello, D D Wood, C Ackerley, C Boulias
Title and authors | Publication | Year |
---|---|---|
Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis
N Wegner, K Lundberg, A Kinloch, B Fisher, V Malmström, M Feldmann, PJ Venables |
Immunological Reviews | 2010 |
Antibodies to citrullinated proteins: molecular interactions and arthritogenicity
H Uysal, KS Nandakumar, C Kessel, S Haag, S Carlsen, H Burkhardt, R Holmdahl |
Immunological Reviews | 2010 |
Antibodies against cyclic citrullinated peptides in infectious diseases—a systematic review
I Lima, M Santiago |
Clinical Rheumatology | 2010 |
Defining the chromatin landscape in demyelinating disorders
JL Huynh, P Casaccia |
Neurobiology of Disease | 2010 |
A technique for the specific enrichment of citrulline-containing peptides
AE Tutturen, A Holm, M Jørgensen, P Stadtmüller, F Rise, B Fleckenstein |
Analytical Biochemistry | 2010 |
Peptidylarginine deiminase 4 and citrullination in health and disease
C Anzilotti, F Pratesi, C Tommasi, P Migliorini |
Autoimmunity Reviews | 2010 |
Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers--are they the cause or the consequence of the disease?
MA Karsdal, K Henriksen, DJ Leeming, T Woodworth, E Vassiliadis, AC Bay-Jensen |
Clinical Biochemistry | 2010 |
Influence of neurosteroids on the pathogenesis of multiple sclerosis
H Leitner |
Medical Hypotheses | 2010 |
Peptidyl arginine deiminase: A novel immunohistochemical marker for liver fibrosis in patients with chronic hepatitis
SM Abdeen, SO Olusi |
Acta Histochemica | 2010 |
Peptidylarginine Deiminase 2 Suppresses Inhibitory κB Kinase Activity in Lipopolysaccharide-stimulated RAW 264.7 Macrophages
HJ Lee, M Joo, R Abdolrasulnia, DG Young, I Choi, LB Ware, TS Blackwell, BW Christman |
The Journal of biological chemistry | 2010 |
Myelin Basic Protein and Myelin Protein 2 Act Synergistically to Cause Stacking of Lipid Bilayers
S Suresh, C Wang, R Nanekar, P Kursula, JM Edwardson |
Biochemistry | 2010 |
Contribution of Myelin Autoantigen Citrullination to T Cell Autoaggression in the Central Nervous System
A Carrillo-Vico, MD Leech, SM Anderton |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
Secondary Structure and Solvent Accessibility of a Calmodulin-Binding C-Terminal Segment of Membrane-Associated Myelin Basic Protein
L Homchaudhuri, MD Avila, SB Nilsson, K Bessonov, GS Smith, VV Bamm, AA Musse, G Harauz, JM Boggs |
Biochemistry | 2010 |